Clinical Validation of Medasense Pain Response Index (PRI)

NCT01762332 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Surgery
Pain

Interventions

DRUG: Base level of remifentanil effect side concentration: 2ng/ml
DRUG: Base level of remifentanil effect side concentration: 4ng/ml
OTHER: chronic beta-blocker treatment

Sponsor

Medasense Biometrics Ltd